Related Experiment Video
Updated: Jun 5, 2025

Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids
Published on: January 6, 2023
A Case of Primary Ovarian Primitive Neuroectodermal Tumor
Sara Parviz1,2, Fahimeh Zeinalkhani1,2, Masoumeh Gity1,2
1Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran.
Peripheral primitive neuroectodermal tumors (pPNET) are rare malignant neoplasms. This case highlights ovarian pPNET in a young woman, emphasizing its consideration in pelvic tumor diagnoses.
Area of Science:
- Oncology
- Pathology
- Radiology
Background:
- Primitive neuroectodermal tumors (PNET) are malignant neoplasms of neuroectodermal origin.
- Peripheral PNET (pPNET) is an uncommon subtype occurring outside the central nervous system.
- Ovarian pPNET is exceedingly rare and associated with high mortality.
Purpose of the Study:
- To report a rare case of peripheral primitive neuroectodermal tumor originating in the ovary.
- To discuss the diagnostic considerations for ovarian pPNET in young women.
Main Methods:
- Case report of a young woman with a pelvic tumor.
- Diagnostic imaging included Ultrasound and Magnetic Resonance Imaging (MRI).
- Microscopic evaluation and Immunohistochemical (IHC) analysis for MIC2 protein (CD99).
Main Results:
- Imaging revealed a high-grade malignant ovarian tumor.
- Microscopically, the tumor consisted of small, rounded cells in nests and sheets.
- IHC confirmed intense CD99 immunoactivity on the cell membrane of tumor cells.
Conclusions:
- Peripheral primitive neuroectodermal tumor should be considered in the differential diagnosis of invasive pelvic tumors in young women.
- Early and accurate diagnosis is crucial for managing this rare and aggressive ovarian malignancy.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
08:17Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells
Published on: December 9, 2016